Get started
Palisade Bio, Inc.Palisade Bio, Inc.Palisade Bio, Inc.

Palisade Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PALI chart


Full chart

Key facts today

Brookline Capital set a price target of $38.00 per share for Palisade Bio, Inc. (PALI).
Analyze the impactAnalyze the impact

PALI upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.24 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−15.04 USD
Net income (FY)
‪−12.32 M‬ USD
Revenue (FY)
‪250.00 K‬ USD
Shares float
‪1.31 M‬
Beta (1Y)
1.20

Employees


Employees (FY)
9
Change (1Y)
−3 −25.00%
Revenue / Employee (1Y)
‪27.78 K‬ USD
Net income / Employee (1Y)
‪−1.37 M‬ USD

About Palisade Bio, Inc.


Sector
Health Technology
CEO
J. D. Finley
Headquarters
Carlsbad
Website
palisadebio.com
Founded
2011
FIGI
BBG000QG4DJ2
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PALI news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PALI is 2.44 USD — it has increased by 0.41% in the past 24 hours. Watch Palisade Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Palisade Bio, Inc. stocks are traded under the ticker PALI.
PALI stock has fallen by −0.81% compared to the previous week, the month change is a −42.99% fall, over the last year Palisade Bio, Inc. has showed a −72.89% decrease.
We've gathered analysts' opinions on Palisade Bio, Inc. future price: according to them, PALI price has a max estimate of 45.00 USD and a min estimate of 8.00 USD. Watch PALI chart and read a more detailed Palisade Bio, Inc. stock forecast: see what analysts think of Palisade Bio, Inc. and suggest that you do with its stocks.
PALI reached its all-time high on Jun 4, 2014 with the price of 5,629,087.38 USD, and its all-time low was 2.18 USD and was reached on Oct 31, 2024. View more price dynamics on PALI chart.
See other stocks reaching their highest and lowest prices.
PALI stock is 22.98% volatile and has beta coefficient of 1.20. Track Palisade Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Palisade Bio, Inc. there?
Today Palisade Bio, Inc. has the market capitalization of ‪3.24 M‬, it has increased by 10.45% over the last week.
Yes, you can track Palisade Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Palisade Bio, Inc. is going to release the next earnings report on Mar 14, 2025. Keep track of upcoming events with our Earnings Calendar.
PALI earnings for the last quarter are −2.32 USD per share, whereas the estimation was −3.35 USD resulting in a 30.80% surprise. The estimated earnings for the next quarter are −2.24 USD per share. See more details about Palisade Bio, Inc. earnings.
PALI net income for the last quarter is ‪−3.49 M‬ USD, while the quarter before that showed ‪−4.08 M‬ USD of net income which accounts for 14.53% change. Track more Palisade Bio, Inc. financial stats to get the full picture.
No, PALI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 9.00 employees. See our rating of the largest employees — is Palisade Bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Palisade Bio, Inc. EBITDA is ‪−14.77 M‬ USD, and current EBITDA margin is ‪−5.14 K‬%. See more stats in Palisade Bio, Inc. financial statements.
Like other stocks, PALI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Palisade Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Palisade Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Palisade Bio, Inc. stock shows the sell signal. See more of Palisade Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.